BLASTP 2.2.26 [Sep-21-2011]


Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer, 
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997), 
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs",  Nucleic Acids Res. 25:3389-3402.


Reference for compositional score matrix adjustment: Altschul, Stephen F., 
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.

Query= 045125
         (342 letters)

Database: pdbaa 
           62,578 sequences; 14,973,337 total letters

Searching..................................................done



>pdb|4BCQ|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
           2-amino-4- Heteroaryl-pyrimidine Inhibitor
          Length = 262

 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 37/209 (17%)

Query: 74  LLEKECHHLPHNDYLKRLRTGDLDLAARQEAVDWIAKVHSHFGFGPLCSYLTINYLDRFL 133
           L E E    P   Y+K+    D+  + R   VDW+ +V   +       +L +NY+DRFL
Sbjct: 16  LREMEVKCKPKVGYMKK--QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFL 73

Query: 134 SAYELPKGKVWMMQLLAVACLSLAAKMEETEVPLCLDLQVGQSKFL----FEAKTIQRME 189
           S+  + +GK   +QL+  A + LA+K EE   P     +V +  ++    +  K + RME
Sbjct: 74  SSMSVLRGK---LQLVGTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRME 125

Query: 190 LLVLSTLKWRMQAITPFSFL-DYFTRKITDDDDDHHQTPLRALFCR--SIQIITSSIKGI 246
            LVL  L + + A T   FL  YF           HQ P     C+  S+ +    +  I
Sbjct: 126 HLVLKVLTFDLAAPTVNQFLTQYFL----------HQQPAN---CKVESLAMFLGELSLI 172

Query: 247 D---FLEFKPSEIAAA----VAISVTGET 268
           D   +L++ PS IAAA       +VTG++
Sbjct: 173 DADPYLKYLPSVIAAAAFHLALYTVTGQS 201


>pdb|4BCO|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
           2-amino-4- Heteroaryl-pyrimidine Inhibitor
 pdb|4BCO|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
           2-amino-4- Heteroaryl-pyrimidine Inhibitor
          Length = 262

 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 37/209 (17%)

Query: 74  LLEKECHHLPHNDYLKRLRTGDLDLAARQEAVDWIAKVHSHFGFGPLCSYLTINYLDRFL 133
           L E E    P   Y+K+    D+  + R   VDW+ +V   +       +L +NY+DRFL
Sbjct: 16  LREMEVKCKPKVGYMKK--QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFL 73

Query: 134 SAYELPKGKVWMMQLLAVACLSLAAKMEETEVPLCLDLQVGQSKFL----FEAKTIQRME 189
           S+  + +GK   +QL+  A + LA+K EE   P     +V +  ++    +  K + RME
Sbjct: 74  SSMSVLRGK---LQLVGTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRME 125

Query: 190 LLVLSTLKWRMQAITPFSFL-DYFTRKITDDDDDHHQTPLRALFCR--SIQIITSSIKGI 246
            LVL  L + + A T   FL  YF           HQ P     C+  S+ +    +  I
Sbjct: 126 HLVLKVLTFDLAAPTVNQFLTQYFL----------HQQPAN---CKVESLAMFLGELSLI 172

Query: 247 D---FLEFKPSEIAAA----VAISVTGET 268
           D   +L++ PS IAAA       +VTG++
Sbjct: 173 DADPYLKYLPSVIAAAAFHLALYTVTGQS 201


>pdb|4BCQ|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
           2-amino-4- Heteroaryl-pyrimidine Inhibitor
          Length = 262

 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 37/209 (17%)

Query: 74  LLEKECHHLPHNDYLKRLRTGDLDLAARQEAVDWIAKVHSHFGFGPLCSYLTINYLDRFL 133
           L E E    P   Y+K+    D+  + R   VDW+ +V   +       +L +NY+DRFL
Sbjct: 16  LREMEVKCKPKVGYMKK--QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFL 73

Query: 134 SAYELPKGKVWMMQLLAVACLSLAAKMEETEVPLCLDLQVGQSKFL----FEAKTIQRME 189
           S+  + +GK   +QL+  A + LA+K EE   P     +V +  ++    +  K + RME
Sbjct: 74  SSMSVLRGK---LQLVGTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRME 125

Query: 190 LLVLSTLKWRMQAITPFSFL-DYFTRKITDDDDDHHQTPLRALFCR--SIQIITSSIKGI 246
            LVL  L + + A T   FL  YF           HQ P     C+  S+ +    +  I
Sbjct: 126 HLVLKVLTFDLAAPTVNQFLTQYFL----------HQQPAN---CKVESLAMFLGELSLI 172

Query: 247 D---FLEFKPSEIAAA----VAISVTGET 268
           D   +L++ PS IAAA       +VTG++
Sbjct: 173 DADPYLKYLPSVIAAAAFHLALYTVTGQS 201


>pdb|3DDQ|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Roscovitine
 pdb|3DDQ|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Roscovitine
          Length = 269

 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 37/209 (17%)

Query: 74  LLEKECHHLPHNDYLKRLRTGDLDLAARQEAVDWIAKVHSHFGFGPLCSYLTINYLDRFL 133
           L E E    P   Y+K+    D+  + R   VDW+ +V   +       +L +NY+DRFL
Sbjct: 16  LREMEVKCKPKVGYMKK--QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFL 73

Query: 134 SAYELPKGKVWMMQLLAVACLSLAAKMEETEVPLCLDLQVGQSKFL----FEAKTIQRME 189
           S+  + +GK   +QL+  A + LA+K EE   P     +V +  ++    +  K + RME
Sbjct: 74  SSMSVLRGK---LQLVGTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRME 125

Query: 190 LLVLSTLKWRMQAITPFSFL-DYFTRKITDDDDDHHQTPLRALFCR--SIQIITSSIKGI 246
            LVL  L + + A T   FL  YF           HQ P     C+  S+ +    +  I
Sbjct: 126 HLVLKVLAFDLAAPTINQFLTQYFL----------HQQPAN---CKVESLAMFLGELSLI 172

Query: 247 D---FLEFKPSEIAAA----VAISVTGET 268
           D   +L++ PS IAAA       +VTG++
Sbjct: 173 DADPYLKYLPSVIAAAAFHLALYTVTGQS 201


>pdb|3DDP|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Cr8
 pdb|3DDP|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Cr8
          Length = 268

 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 37/209 (17%)

Query: 74  LLEKECHHLPHNDYLKRLRTGDLDLAARQEAVDWIAKVHSHFGFGPLCSYLTINYLDRFL 133
           L E E    P   Y+K+    D+  + R   VDW+ +V   +       +L +NY+DRFL
Sbjct: 16  LREMEVKCKPKVGYMKK--QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFL 73

Query: 134 SAYELPKGKVWMMQLLAVACLSLAAKMEETEVPLCLDLQVGQSKFL----FEAKTIQRME 189
           S+  + +GK   +QL+  A + LA+K EE   P     +V +  ++    +  K + RME
Sbjct: 74  SSMSVLRGK---LQLVGTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRME 125

Query: 190 LLVLSTLKWRMQAITPFSFL-DYFTRKITDDDDDHHQTPLRALFCR--SIQIITSSIKGI 246
            LVL  L + + A T   FL  YF           HQ P     C+  S+ +    +  I
Sbjct: 126 HLVLKVLAFDLAAPTINQFLTQYFL----------HQQPAN---CKVESLAMFLGELSLI 172

Query: 247 D---FLEFKPSEIAAA----VAISVTGET 268
           D   +L++ PS IAAA       +VTG++
Sbjct: 173 DADPYLKYLPSVIAAAAFHLALYTVTGQS 201


>pdb|3BHT|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           WITH THE Inhibitor Meriolin 3
 pdb|3BHT|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           WITH THE Inhibitor Meriolin 3
 pdb|3BHU|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           WITH THE Inhibitor Meriolin 5
 pdb|3BHU|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           WITH THE Inhibitor Meriolin 5
 pdb|3BHV|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Variolin B
 pdb|3BHV|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Variolin B
 pdb|3MY5|B Chain B, Cdk2CYCLINA IN COMPLEX WITH DRB
 pdb|3MY5|D Chain D, Cdk2CYCLINA IN COMPLEX WITH DRB
 pdb|3TNW|B Chain B, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
 pdb|3TNW|D Chain D, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
          Length = 262

 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 37/209 (17%)

Query: 74  LLEKECHHLPHNDYLKRLRTGDLDLAARQEAVDWIAKVHSHFGFGPLCSYLTINYLDRFL 133
           L E E    P   Y+K+    D+  + R   VDW+ +V   +       +L +NY+DRFL
Sbjct: 16  LREMEVKCKPKVGYMKK--QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFL 73

Query: 134 SAYELPKGKVWMMQLLAVACLSLAAKMEETEVPLCLDLQVGQSKFL----FEAKTIQRME 189
           S+  + +GK   +QL+  A + LA+K EE   P     +V +  ++    +  K + RME
Sbjct: 74  SSMSVLRGK---LQLVGTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRME 125

Query: 190 LLVLSTLKWRMQAITPFSFL-DYFTRKITDDDDDHHQTPLRALFCR--SIQIITSSIKGI 246
            LVL  L + + A T   FL  YF           HQ P     C+  S+ +    +  I
Sbjct: 126 HLVLKVLAFDLAAPTINQFLTQYFL----------HQQPAN---CKVESLAMFLGELSLI 172

Query: 247 D---FLEFKPSEIAAA----VAISVTGET 268
           D   +L++ PS IAAA       +VTG++
Sbjct: 173 DADPYLKYLPSVIAAAAFHLALYTVTGQS 201


>pdb|2G9X|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
           COMPLEX WITH THE Inhibitor Nu6271
 pdb|2G9X|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
           COMPLEX WITH THE Inhibitor Nu6271
          Length = 262

 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 37/209 (17%)

Query: 74  LLEKECHHLPHNDYLKRLRTGDLDLAARQEAVDWIAKVHSHFGFGPLCSYLTINYLDRFL 133
           L E E    P   Y+K+    D+  + R   VDW+ +V   +       +L +NY+DRFL
Sbjct: 16  LREMEVKCKPKVGYMKK--QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFL 73

Query: 134 SAYELPKGKVWMMQLLAVACLSLAAKMEETEVPLCLDLQVGQSKFL----FEAKTIQRME 189
           S+  + +GK   +QL+  A + LA+K EE   P     +V +  ++    +  K + RME
Sbjct: 74  SSMSVLRGK---LQLVGTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRME 125

Query: 190 LLVLSTLKWRMQAITPFSFL-DYFTRKITDDDDDHHQTPLRALFCR--SIQIITSSIKGI 246
            LVL  L + + A T   FL  YF           HQ P     C+  S+ +    +  I
Sbjct: 126 HLVLKVLAFDLAAPTINQFLTQYFL----------HQQPAN---CKVESLAMFLGELSLI 172

Query: 247 D---FLEFKPSEIAAA----VAISVTGET 268
           D   +L++ PS IAAA       +VTG++
Sbjct: 173 DADPYLKYLPSVIAAAAFHLALYTVTGQS 201


>pdb|1VIN|A Chain A, Bovine Cyclin A3
          Length = 268

 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 37/209 (17%)

Query: 74  LLEKECHHLPHNDYLKRLRTGDLDLAARQEAVDWIAKVHSHFGFGPLCSYLTINYLDRFL 133
           L E E    P   Y+K+    D+  + R   VDW+ +V   +       +L +NY+DRFL
Sbjct: 16  LREMEVKCKPKVGYMKK--QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFL 73

Query: 134 SAYELPKGKVWMMQLLAVACLSLAAKMEETEVPLCLDLQVGQSKFL----FEAKTIQRME 189
           S+  + +GK   +QL+  A + LA+K EE   P     +V +  ++    +  K + RME
Sbjct: 74  SSMSVLRGK---LQLVGTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRME 125

Query: 190 LLVLSTLKWRMQAITPFSFL-DYFTRKITDDDDDHHQTPLRALFCR--SIQIITSSIKGI 246
            LVL  L + + A T   FL  YF           HQ P     C+  S+ +    +  I
Sbjct: 126 HLVLKVLAFDLAAPTINQFLTQYFL----------HQQPAN---CKVESLAMFLGELSLI 172

Query: 247 D---FLEFKPSEIAAA----VAISVTGET 268
           D   +L++ PS IAAA       +VTG++
Sbjct: 173 DADPYLKYLPSVIAAAAFHLALYTVTGQS 201


>pdb|3DOG|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
           Complex With The Inhibitor N-&-N1
 pdb|3DOG|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
           Complex With The Inhibitor N-&-N1
          Length = 264

 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 37/209 (17%)

Query: 74  LLEKECHHLPHNDYLKRLRTGDLDLAARQEAVDWIAKVHSHFGFGPLCSYLTINYLDRFL 133
           L E E    P   Y+K+    D+  + R   VDW+ +V   +       +L +NY+DRFL
Sbjct: 16  LREMEVKCKPKVGYMKK--QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFL 73

Query: 134 SAYELPKGKVWMMQLLAVACLSLAAKMEETEVPLCLDLQVGQSKFL----FEAKTIQRME 189
           S+  + +GK   +QL+  A + LA+K EE   P     +V +  ++    +  K + RME
Sbjct: 74  SSMSVLRGK---LQLVGTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRME 125

Query: 190 LLVLSTLKWRMQAITPFSFL-DYFTRKITDDDDDHHQTPLRALFCR--SIQIITSSIKGI 246
            LVL  L + + A T   FL  YF           HQ P     C+  S+ +    +  I
Sbjct: 126 HLVLKVLAFDLAAPTINQFLTQYFL----------HQQPAN---CKVESLAMFLGELSLI 172

Query: 247 D---FLEFKPSEIAAA----VAISVTGET 268
           D   +L++ PS IAAA       +VTG++
Sbjct: 173 DADPYLKYLPSVIAAAAFHLALYTVTGQS 201


>pdb|1OGU|B Chain B, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
           With A
           2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
           aminopyrimidine Inhibitor
 pdb|1OGU|D Chain D, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
           With A
           2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
           aminopyrimidine Inhibitor
 pdb|1OI9|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|1OI9|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|1OIU|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|1OIU|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|1OIY|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|1OIY|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|2IW6|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
           With A Bisanilinopyrimidine Inhibitor
 pdb|2IW6|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
           With A Bisanilinopyrimidine Inhibitor
 pdb|2IW8|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
           H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
 pdb|2IW8|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
           H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
 pdb|2IW9|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
           With A Bisanilinopyrimidine Inhibitor
 pdb|2IW9|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
           With A Bisanilinopyrimidine Inhibitor
          Length = 260

 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 37/222 (16%)

Query: 61  LSLPLQSDECLALLLEKECHHLPHNDYLKRLRTGDLDLAARQEAVDWIAKVHSHFGFGPL 120
           + +P   ++    L E E    P   Y+K+    D+  + R   VDW+ +V   +     
Sbjct: 1   MEVPDYHEDIHTYLREMEVKCKPKVGYMKK--QPDITNSMRAILVDWLVEVGEEYKLQNE 58

Query: 121 CSYLTINYLDRFLSAYELPKGKVWMMQLLAVACLSLAAKMEETEVPLCLDLQVGQSKFL- 179
             +L +NY+DRFLS+  + +GK   +QL+  A + LA+K EE   P     +V +  ++ 
Sbjct: 59  TLHLAVNYIDRFLSSMSVLRGK---LQLVGTAAMLLASKFEEIYPP-----EVAEFVYIT 110

Query: 180 ---FEAKTIQRMELLVLSTLKWRMQAITPFSFL-DYFTRKITDDDDDHHQTPLRALFCR- 234
              +  K + RME LVL  L + + A T   FL  YF           HQ P     C+ 
Sbjct: 111 DDTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFL----------HQQPAN---CKV 157

Query: 235 -SIQIITSSIKGID---FLEFKPSEIAAA----VAISVTGET 268
            S+ +    +  ID   +L++ PS IA A       +VTG++
Sbjct: 158 ESLAMFLGELSLIDADPYLKYLPSVIAGAAFHLALYTVTGQS 199


>pdb|2X1N|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2X1N|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
          Length = 261

 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 37/209 (17%)

Query: 74  LLEKECHHLPHNDYLKRLRTGDLDLAARQEAVDWIAKVHSHFGFGPLCSYLTINYLDRFL 133
           L E E    P   Y+K+    D+  + R   VDW+ +V   +       +L +NY+DRFL
Sbjct: 15  LREMEVKCKPKVGYMKK--QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFL 72

Query: 134 SAYELPKGKVWMMQLLAVACLSLAAKMEETEVPLCLDLQVGQSKFL----FEAKTIQRME 189
           S+  + +GK   +QL+  A + LA+K EE   P     +V +  ++    +  K + RME
Sbjct: 73  SSMSVLRGK---LQLVGTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRME 124

Query: 190 LLVLSTLKWRMQAITPFSFL-DYFTRKITDDDDDHHQTPLRALFCR--SIQIITSSIKGI 246
            LVL  L + + A T   FL  YF           HQ P     C+  S+ +    +  I
Sbjct: 125 HLVLKVLTFDLAAPTVNQFLTQYFL----------HQQPAN---CKVESLAMFLGELSLI 171

Query: 247 D---FLEFKPSEIAAA----VAISVTGET 268
           D   +L++ PS IA A       +VTG++
Sbjct: 172 DADPYLKYLPSVIAGAAFHLALYTVTGQS 200


>pdb|1VYW|B Chain B, Structure Of Cdk2CYCLIN A WITH PNU-292137
 pdb|1VYW|D Chain D, Structure Of Cdk2CYCLIN A WITH PNU-292137
 pdb|2C4G|B Chain B, Structure Of Cdk2-Cyclin A With Pha-533514
 pdb|2C4G|D Chain D, Structure Of Cdk2-Cyclin A With Pha-533514
 pdb|2BPM|B Chain B, Structure Of Cdk2-Cyclin A With Pha-630529
 pdb|2BPM|D Chain D, Structure Of Cdk2-Cyclin A With Pha-630529
 pdb|2BKZ|B Chain B, Structure Of Cdk2-Cyclin A With Pha-404611
 pdb|2BKZ|D Chain D, Structure Of Cdk2-Cyclin A With Pha-404611
 pdb|2WIH|B Chain B, Structure Of Cdk2-Cyclin A With Pha-848125
 pdb|2WIH|D Chain D, Structure Of Cdk2-Cyclin A With Pha-848125
 pdb|2WIP|B Chain B, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
           Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
           Carboxylic Acid
 pdb|2WIP|D Chain D, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
           Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
           Carboxylic Acid
 pdb|2WPA|B Chain B, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
           Identification Of Pha-793887, A Potent Cdk Inhibitor
           Suitable For Intravenous Dosing
 pdb|2WPA|D Chain D, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
           Identification Of Pha-793887, A Potent Cdk Inhibitor
           Suitable For Intravenous Dosing
 pdb|2WXV|B Chain B, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
           Quinazoline-3-Carboxamide Inhibitor
 pdb|2WXV|D Chain D, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
           Quinazoline-3-Carboxamide Inhibitor
          Length = 265

 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 37/209 (17%)

Query: 74  LLEKECHHLPHNDYLKRLRTGDLDLAARQEAVDWIAKVHSHFGFGPLCSYLTINYLDRFL 133
           L E E    P   Y+K+    D+  + R   VDW+ +V   +       +L +NY+DRFL
Sbjct: 19  LREMEVKCKPKVGYMKK--QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFL 76

Query: 134 SAYELPKGKVWMMQLLAVACLSLAAKMEETEVPLCLDLQVGQSKFL----FEAKTIQRME 189
           S+  + +GK   +QL+  A + LA+K EE   P     +V +  ++    +  K + RME
Sbjct: 77  SSMSVLRGK---LQLVGTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRME 128

Query: 190 LLVLSTLKWRMQAITPFSFL-DYFTRKITDDDDDHHQTPLRALFCR--SIQIITSSIKGI 246
            LVL  L + + A T   FL  YF           HQ P     C+  S+ +    +  I
Sbjct: 129 HLVLKVLTFDLAAPTVNQFLTQYFL----------HQQPAN---CKVESLAMFLGELSLI 175

Query: 247 D---FLEFKPSEIAAA----VAISVTGET 268
           D   +L++ PS IA A       +VTG++
Sbjct: 176 DADPYLKYLPSVIAGAAFHLALYTVTGQS 204


>pdb|1E9H|B Chain B, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
           The Inhibitor Indirubin-5-Sulphonate Bound
 pdb|1E9H|D Chain D, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
           The Inhibitor Indirubin-5-Sulphonate Bound
          Length = 261

 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 37/209 (17%)

Query: 74  LLEKECHHLPHNDYLKRLRTGDLDLAARQEAVDWIAKVHSHFGFGPLCSYLTINYLDRFL 133
           L E E    P   Y+K+    D+  + R   VDW+ +V   +       +L +NY+DRFL
Sbjct: 12  LREMEVKCKPKVGYMKK--QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFL 69

Query: 134 SAYELPKGKVWMMQLLAVACLSLAAKMEETEVPLCLDLQVGQSKFL----FEAKTIQRME 189
           S+  + +GK   +QL+  A + LA+K EE   P     +V +  ++    +  K + RME
Sbjct: 70  SSMSVLRGK---LQLVGTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRME 121

Query: 190 LLVLSTLKWRMQAITPFSFL-DYFTRKITDDDDDHHQTPLRALFCR--SIQIITSSIKGI 246
            LVL  L + + A T   FL  YF           HQ P     C+  S+ +    +  I
Sbjct: 122 HLVLKVLTFDLAAPTVNQFLTQYFL----------HQQPAN---CKVESLAMFLGELSLI 168

Query: 247 D---FLEFKPSEIAAA----VAISVTGET 268
           D   +L++ PS IA A       +VTG++
Sbjct: 169 DADPYLKYLPSVIAGAAFHLALYTVTGQS 197


>pdb|1FIN|B Chain B, Cyclin A-Cyclin-Dependent Kinase 2 Complex
 pdb|1FIN|D Chain D, Cyclin A-Cyclin-Dependent Kinase 2 Complex
 pdb|1JSU|B Chain B, P27(Kip1)CYCLIN ACDK2 COMPLEX
 pdb|1FVV|B Chain B, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
           Inhibitor
 pdb|1FVV|D Chain D, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
           Inhibitor
 pdb|1OKV|B Chain B, Cyclin A Binding Groove Inhibitor
           H-Arg-Arg-Leu-Ile-Phe-Nh2
 pdb|1OKV|D Chain D, Cyclin A Binding Groove Inhibitor
           H-Arg-Arg-Leu-Ile-Phe-Nh2
 pdb|1OKW|B Chain B, Cyclin A Binding Groove Inhibitor
           Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
 pdb|1OKW|D Chain D, Cyclin A Binding Groove Inhibitor
           Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
 pdb|1OL1|B Chain B, Cyclin A Binding Groove Inhibitor
           H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
 pdb|1OL1|D Chain D, Cyclin A Binding Groove Inhibitor
           H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
 pdb|1OL2|B Chain B, Cyclin A Binding Groove Inhibitor
           H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
 pdb|1OL2|D Chain D, Cyclin A Binding Groove Inhibitor
           H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
 pdb|1URC|B Chain B, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
 pdb|1URC|D Chain D, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
 pdb|2C5O|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5O|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2CCH|B Chain B, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
           Substrate Peptide Derived From Cdc Modified With A
           Gamma- Linked Atp Analogue
 pdb|2CCH|D Chain D, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
           Substrate Peptide Derived From Cdc Modified With A
           Gamma- Linked Atp Analogue
 pdb|2I40|B Chain B, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
           INHIBITOR
 pdb|2I40|D Chain D, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
           INHIBITOR
 pdb|3EID|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
 pdb|3EID|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
 pdb|3EJ1|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
 pdb|3EJ1|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
 pdb|3EOC|B Chain B, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
 pdb|3EOC|D Chain D, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
 pdb|2WEV|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2WEV|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2WFY|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2WFY|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2WHB|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2WHB|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
          Length = 260

 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 37/209 (17%)

Query: 74  LLEKECHHLPHNDYLKRLRTGDLDLAARQEAVDWIAKVHSHFGFGPLCSYLTINYLDRFL 133
           L E E    P   Y+K+    D+  + R   VDW+ +V   +       +L +NY+DRFL
Sbjct: 14  LREMEVKCKPKVGYMKK--QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFL 71

Query: 134 SAYELPKGKVWMMQLLAVACLSLAAKMEETEVPLCLDLQVGQSKFL----FEAKTIQRME 189
           S+  + +GK   +QL+  A + LA+K EE   P     +V +  ++    +  K + RME
Sbjct: 72  SSMSVLRGK---LQLVGTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRME 123

Query: 190 LLVLSTLKWRMQAITPFSFL-DYFTRKITDDDDDHHQTPLRALFCR--SIQIITSSIKGI 246
            LVL  L + + A T   FL  YF           HQ P     C+  S+ +    +  I
Sbjct: 124 HLVLKVLTFDLAAPTVNQFLTQYFL----------HQQPAN---CKVESLAMFLGELSLI 170

Query: 247 D---FLEFKPSEIAAA----VAISVTGET 268
           D   +L++ PS IA A       +VTG++
Sbjct: 171 DADPYLKYLPSVIAGAAFHLALYTVTGQS 199


>pdb|1QMZ|B Chain B, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
 pdb|1QMZ|D Chain D, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
 pdb|1H24|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
           Peptide From E2f
 pdb|1H24|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
           Peptide From E2f
 pdb|1H25|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From Retinoblastoma-Associated Protein
 pdb|1H25|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From Retinoblastoma-Associated Protein
 pdb|1H26|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From P53
 pdb|1H26|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From P53
 pdb|1H27|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From P27
 pdb|1H27|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From P27
 pdb|1H28|B Chain B, Cdk2/cyclin A In Complex With An 11-residue Recruitment
           Peptide From P107
 pdb|1H28|D Chain D, Cdk2/cyclin A In Complex With An 11-residue Recruitment
           Peptide From P107
 pdb|2C5N|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5N|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5V|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5V|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5X|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5X|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2UUE|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
           Groove Inhibitors
 pdb|2UUE|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
           Groove Inhibitors
 pdb|2V22|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
           Groove Inhibitors
 pdb|2V22|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
           Groove Inhibitors
 pdb|2WMA|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
           Of Peptide Ligands For The Recruitment Site Of Cyclin A
 pdb|2WMA|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
           Of Peptide Ligands For The Recruitment Site Of Cyclin A
 pdb|2WMB|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
           Of Peptide Ligands For The Recruitment Site Of Cyclin A
 pdb|2WMB|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
           Of Peptide Ligands For The Recruitment Site Of Cyclin A
          Length = 259

 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 37/209 (17%)

Query: 74  LLEKECHHLPHNDYLKRLRTGDLDLAARQEAVDWIAKVHSHFGFGPLCSYLTINYLDRFL 133
           L E E    P   Y+K+    D+  + R   VDW+ +V   +       +L +NY+DRFL
Sbjct: 13  LREMEVKCKPKVGYMKK--QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFL 70

Query: 134 SAYELPKGKVWMMQLLAVACLSLAAKMEETEVPLCLDLQVGQSKFL----FEAKTIQRME 189
           S+  + +GK   +QL+  A + LA+K EE   P     +V +  ++    +  K + RME
Sbjct: 71  SSMSVLRGK---LQLVGTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRME 122

Query: 190 LLVLSTLKWRMQAITPFSFL-DYFTRKITDDDDDHHQTPLRALFCR--SIQIITSSIKGI 246
            LVL  L + + A T   FL  YF           HQ P     C+  S+ +    +  I
Sbjct: 123 HLVLKVLTFDLAAPTVNQFLTQYFL----------HQQPAN---CKVESLAMFLGELSLI 169

Query: 247 D---FLEFKPSEIAAA----VAISVTGET 268
           D   +L++ PS IA A       +VTG++
Sbjct: 170 DADPYLKYLPSVIAGAAFHLALYTVTGQS 198


>pdb|3F5X|B Chain B, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
           Its Active Site
 pdb|3F5X|D Chain D, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
           Its Active Site
          Length = 256

 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 37/209 (17%)

Query: 74  LLEKECHHLPHNDYLKRLRTGDLDLAARQEAVDWIAKVHSHFGFGPLCSYLTINYLDRFL 133
           L E E    P   Y+K+    D+  + R   VDW+ +V   +       +L +NY+DRFL
Sbjct: 10  LREMEVKCKPKVGYMKK--QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFL 67

Query: 134 SAYELPKGKVWMMQLLAVACLSLAAKMEETEVPLCLDLQVGQSKFL----FEAKTIQRME 189
           S+  + +GK   +QL+  A + LA+K EE   P     +V +  ++    +  K + RME
Sbjct: 68  SSMSVLRGK---LQLVGTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRME 119

Query: 190 LLVLSTLKWRMQAITPFSFL-DYFTRKITDDDDDHHQTPLRALFCR--SIQIITSSIKGI 246
            LVL  L + + A T   FL  YF           HQ P     C+  S+ +    +  I
Sbjct: 120 HLVLKVLTFDLAAPTVNQFLTQYFL----------HQQPAN---CKVESLAMFLGELSLI 166

Query: 247 D---FLEFKPSEIAAA----VAISVTGET 268
           D   +L++ PS IA A       +VTG++
Sbjct: 167 DADPYLKYLPSVIAGAAFHLALYTVTGQS 195


>pdb|1JST|B Chain B, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
 pdb|1JST|D Chain D, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
 pdb|1GY3|B Chain B, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
           SUBSTRATE
 pdb|1GY3|D Chain D, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
           SUBSTRATE
 pdb|1H1P|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu2058
 pdb|1H1P|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu2058
 pdb|1H1Q|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6094
 pdb|1H1Q|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6094
 pdb|1H1R|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6086
 pdb|1H1R|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6086
 pdb|1H1S|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6102
 pdb|1H1S|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6102
 pdb|1P5E|B Chain B, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
           Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
 pdb|1P5E|D Chain D, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
           Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
 pdb|1PKD|B Chain B, The Crystal Structure Of Ucn-01 In Complex With Phospho-
           Cdk2CYCLIN A
 pdb|1PKD|D Chain D, The Crystal Structure Of Ucn-01 In Complex With Phospho-
           Cdk2CYCLIN A
 pdb|2C6T|B Chain B, Crystal Structure Of The Human Cdk2 Complexed With The
           Triazolopyrimidine Inhibitor
 pdb|2C6T|D Chain D, Crystal Structure Of The Human Cdk2 Complexed With The
           Triazolopyrimidine Inhibitor
 pdb|2CJM|B Chain B, Mechanism Of Cdk Inhibition By Active Site
           Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
           A Structure
 pdb|2CJM|D Chain D, Mechanism Of Cdk Inhibition By Active Site
           Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
           A Structure
 pdb|2CCI|B Chain B, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
           A Peptide Containing Both The Substrate And Recruitment
           Sites Of Cdc6
 pdb|2CCI|D Chain D, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
           A Peptide Containing Both The Substrate And Recruitment
           Sites Of Cdc6
 pdb|2UZB|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZB|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZD|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZD|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZE|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZE|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZL|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZL|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|4EOI|B Chain B, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
           Complex With The Inhibitor Ro3306
 pdb|4EOI|D Chain D, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
           Complex With The Inhibitor Ro3306
 pdb|4EOJ|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With Atp
 pdb|4EOJ|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With Atp
 pdb|4EOK|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With The Inhibitor Nu6102
 pdb|4EOK|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With The Inhibitor Nu6102
 pdb|4EOL|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With The Inhibitor Ro3306
 pdb|4EOL|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With The Inhibitor Ro3306
 pdb|4EOM|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
           Cyclin A3 Complex With Atp
 pdb|4EOM|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
           Cyclin A3 Complex With Atp
 pdb|4EON|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
           Cyclin A3 Complex With The Inhibitor Ro3306
 pdb|4EON|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
           Cyclin A3 Complex With The Inhibitor Ro3306
 pdb|4EOO|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
           Complex With Atp
 pdb|4EOO|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
           Complex With Atp
 pdb|4EOP|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
           Complex With The Inhibitor Ro3306
 pdb|4EOP|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
           Complex With The Inhibitor Ro3306
 pdb|4EOQ|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With Atp
 pdb|4EOQ|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With Atp
 pdb|4EOR|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With The Inhibitor Nu6102
 pdb|4EOR|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With The Inhibitor Nu6102
 pdb|4EOS|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With The Inhibitor Ro3306
 pdb|4EOS|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With The Inhibitor Ro3306
          Length = 258

 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 37/209 (17%)

Query: 74  LLEKECHHLPHNDYLKRLRTGDLDLAARQEAVDWIAKVHSHFGFGPLCSYLTINYLDRFL 133
           L E E    P   Y+K+    D+  + R   VDW+ +V   +       +L +NY+DRFL
Sbjct: 12  LREMEVKCKPKVGYMKK--QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFL 69

Query: 134 SAYELPKGKVWMMQLLAVACLSLAAKMEETEVPLCLDLQVGQSKFL----FEAKTIQRME 189
           S+  + +GK   +QL+  A + LA+K EE   P     +V +  ++    +  K + RME
Sbjct: 70  SSMSVLRGK---LQLVGTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRME 121

Query: 190 LLVLSTLKWRMQAITPFSFL-DYFTRKITDDDDDHHQTPLRALFCR--SIQIITSSIKGI 246
            LVL  L + + A T   FL  YF           HQ P     C+  S+ +    +  I
Sbjct: 122 HLVLKVLTFDLAAPTVNQFLTQYFL----------HQQPAN---CKVESLAMFLGELSLI 168

Query: 247 D---FLEFKPSEIAAA----VAISVTGET 268
           D   +L++ PS IA A       +VTG++
Sbjct: 169 DADPYLKYLPSVIAGAAFHLALYTVTGQS 197


>pdb|3QHR|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
 pdb|3QHR|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
 pdb|3QHW|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
 pdb|3QHW|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
          Length = 261

 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 37/209 (17%)

Query: 74  LLEKECHHLPHNDYLKRLRTGDLDLAARQEAVDWIAKVHSHFGFGPLCSYLTINYLDRFL 133
           L E E    P   Y+KR    D+  + R   VDW+ +V   +       +L +NY+DRFL
Sbjct: 15  LREMEVKCKPKVGYMKR--QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFL 72

Query: 134 SAYELPKGKVWMMQLLAVACLSLAAKMEETEVPLCLDLQVGQSKFL----FEAKTIQRME 189
           S+  + +GK   +QL+  A + LA+K EE   P     +V +  ++    +  K + RME
Sbjct: 73  SSMSVLRGK---LQLVGTAAMLLASKFEEIYPP-----EVAEFVYITDDTYSKKQVLRME 124

Query: 190 LLVLSTLKWRMQAITPFSFL-DYFTRKITDDDDDHHQTPLRALFCR--SIQIITSSIKGI 246
            LVL  L + + A T   FL  YF               L+   C+  S+ +    +  I
Sbjct: 125 HLVLKVLAFDLAAPTVNQFLTQYFLH-------------LQPANCKVESLAMFLGELSLI 171

Query: 247 D---FLEFKPSEIAAA----VAISVTGET 268
           D   +L++ PS IA A       +VTG++
Sbjct: 172 DADPYLKYLPSLIAGAAFHLALYTVTGQS 200


>pdb|4II5|B Chain B, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
           Ion
 pdb|4II5|D Chain D, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
           Ion
          Length = 258

 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 37/209 (17%)

Query: 74  LLEKECHHLPHNDYLKRLRTGDLDLAARQEAVDWIAKVHSHFGFGPLCSYLTINYLDRFL 133
           L E E    P   Y+KR    D+  + R   VDW+ +V   +       +L +NY+DRFL
Sbjct: 12  LREMEVKCKPKVGYMKR--QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFL 69

Query: 134 SAYELPKGKVWMMQLLAVACLSLAAKMEETEVPLCLDLQVGQSKFL----FEAKTIQRME 189
           S+  + +GK   +QL+  A + LA+K EE   P     +V +  ++    +  K + RME
Sbjct: 70  SSMSVLRGK---LQLVGTAAMLLASKFEEIYPP-----EVAEFVYITDDTYSKKQVLRME 121

Query: 190 LLVLSTLKWRMQAITPFSFL-DYFTRKITDDDDDHHQTPLRALFCR--SIQIITSSIKGI 246
            LVL  L + + A T   FL  YF               L+   C+  S+ +    +  I
Sbjct: 122 HLVLKVLAFDLAAPTVNQFLTQYFLH-------------LQPANCKVESLAMFLGELSLI 168

Query: 247 D---FLEFKPSEIAAA----VAISVTGET 268
           D   +L++ PS IA A       +VTG++
Sbjct: 169 DADPYLKYLPSLIAGAAFHLALYTVTGQS 197


>pdb|4I3Z|B Chain B, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
           IONS
 pdb|4I3Z|D Chain D, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
           IONS
          Length = 257

 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 37/209 (17%)

Query: 74  LLEKECHHLPHNDYLKRLRTGDLDLAARQEAVDWIAKVHSHFGFGPLCSYLTINYLDRFL 133
           L E E    P   Y+KR    D+  + R   VDW+ +V   +       +L +NY+DRFL
Sbjct: 12  LREMEVKCKPKVGYMKR--QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFL 69

Query: 134 SAYELPKGKVWMMQLLAVACLSLAAKMEETEVPLCLDLQVGQSKFL----FEAKTIQRME 189
           S+  + +GK   +QL+  A + LA+K EE   P     +V +  ++    +  K + RME
Sbjct: 70  SSMSVLRGK---LQLVGTAAMLLASKFEEIYPP-----EVAEFVYITDDTYSKKQVLRME 121

Query: 190 LLVLSTLKWRMQAITPFSFL-DYFTRKITDDDDDHHQTPLRALFCR--SIQIITSSIKGI 246
            LVL  L + + A T   FL  YF               L+   C+  S+ +    +  I
Sbjct: 122 HLVLKVLAFDLAAPTVNQFLTQYFLH-------------LQPANCKVESLAMFLGELSLI 168

Query: 247 D---FLEFKPSEIAAA----VAISVTGET 268
           D   +L++ PS IA A       +VTG++
Sbjct: 169 DADPYLKYLPSLIAGAAFHLALYTVTGQS 197


>pdb|2B9R|A Chain A, Crystal Structure Of Human Cyclin B1
 pdb|2B9R|B Chain B, Crystal Structure Of Human Cyclin B1
          Length = 269

 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 109/247 (44%), Gaps = 36/247 (14%)

Query: 88  LKRLRTGDLDLAARQEAVDWIAKVHSHFGFGPLCSYLTINYLDRFLSAYELPKGKVWMMQ 147
           L R  TG++    R   +DW+ +V   F       Y+T++ +DRF+    +PK    M+Q
Sbjct: 29  LGREVTGNM----RAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNSVPKK---MLQ 81

Query: 148 LLAVACLSLAAKMEETEVPLCLDLQVGQSKFL----FEAKTIQRMELLVLSTLKWRMQAI 203
           L+ V  + +A+K EE   P     ++G   F+    +    I++ME+ +L  L + +   
Sbjct: 82  LVGVTAMFIASKYEEMYPP-----EIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRP 136

Query: 204 TPFSFLDYFTRKITDDDDDHHQTPLRALFCRSIQIITSSIKGIDFLEFKPSEIAA----- 258
            P  FL     KI + D + H          +  ++  ++   D + F PS+IAA     
Sbjct: 137 LPLHFLRR-ASKIGEVDVEQH--------TLAKYLMELTMLDYDMVHFPPSQIAAGAFSL 187

Query: 259 AVAISVTGETKTVVD-----TEKAISLLTQHVKKERVLKCIKMMNDSLISGSVKSATSAS 313
           A+ I   GE    +      TE+++  + QH+ K  V+    +     +     ++  A 
Sbjct: 188 ALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAK 247

Query: 314 LATSFPQ 320
           ++T  PQ
Sbjct: 248 IST-LPQ 253


>pdb|2JGZ|B Chain B, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
          Length = 260

 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 109/247 (44%), Gaps = 36/247 (14%)

Query: 88  LKRLRTGDLDLAARQEAVDWIAKVHSHFGFGPLCSYLTINYLDRFLSAYELPKGKVWMMQ 147
           L R  TG++    R   +DW+ +V   F       Y+T++ +DRF+    +PK    M+Q
Sbjct: 27  LGREVTGNM----RAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKK---MLQ 79

Query: 148 LLAVACLSLAAKMEETEVPLCLDLQVGQSKFL----FEAKTIQRMELLVLSTLKWRMQAI 203
           L+ V  + +A+K EE   P     ++G   F+    +    I++ME+ +L  L + +   
Sbjct: 80  LVGVTAMFIASKYEEMYPP-----EIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRP 134

Query: 204 TPFSFLDYFTRKITDDDDDHHQTPLRALFCRSIQIITSSIKGIDFLEFKPSEIAA----- 258
            P  FL     KI + D + H          +  ++  ++   D + F PS+IAA     
Sbjct: 135 LPLHFLRR-ASKIGEVDVEQH--------TLAKYLMELTMLDYDMVHFPPSQIAAGAFCL 185

Query: 259 AVAISVTGETKTVVD-----TEKAISLLTQHVKKERVLKCIKMMNDSLISGSVKSATSAS 313
           A+ I   GE    +      TE+++  + QH+ K  V+    +     +     ++  A 
Sbjct: 186 ALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYATSKHAK 245

Query: 314 LATSFPQ 320
           ++T  PQ
Sbjct: 246 IST-LPQ 251


>pdb|2W9Z|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
          Length = 257

 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 82/160 (51%), Gaps = 5/160 (3%)

Query: 65  LQSDECLALLLEKECHHLPHNDYLKRLRTGDLDLAARQEAVDWIAKVHSHFGFGPLCSYL 124
           L +D  L  +L+ E    P   Y K ++   L  + R+    W+ +V            L
Sbjct: 8   LLNDRVLRAMLKAEETCAPSVSYFKCVQKEVLP-SMRKIVATWMLEVCEEQKCEEEVFPL 66

Query: 125 TINYLDRFLSAYELPKGKVWMMQLLAVACLSLAAKMEETEVPLCLDLQVGQSKFLFEAKT 184
            +NYLDRFLS   + K +   +QLL   C+ +A+KM+ET +PL  +     +      + 
Sbjct: 67  AMNYLDRFLSLEPVKKSR---LQLLGATCMFVASKMKET-IPLTAEKLCIYTDNSIRPEE 122

Query: 185 IQRMELLVLSTLKWRMQAITPFSFLDYFTRKITDDDDDHH 224
           + +MELL+++ LKW + A+TP  F+++F  K+ + +++  
Sbjct: 123 LLQMELLLVNKLKWNLAAMTPHDFIEHFLSKMPEAEENKQ 162


>pdb|2W96|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
 pdb|2W99|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
 pdb|2W9F|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
          Length = 271

 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 82/160 (51%), Gaps = 5/160 (3%)

Query: 65  LQSDECLALLLEKECHHLPHNDYLKRLRTGDLDLAARQEAVDWIAKVHSHFGFGPLCSYL 124
           L +D  L  +L+ E    P   Y K ++   L  + R+    W+ +V            L
Sbjct: 22  LLNDRVLRAMLKAEETCAPSVSYFKCVQKEVLP-SMRKIVATWMLEVCEEQKCEEEVFPL 80

Query: 125 TINYLDRFLSAYELPKGKVWMMQLLAVACLSLAAKMEETEVPLCLDLQVGQSKFLFEAKT 184
            +NYLDRFLS   + K +   +QLL   C+ +A+KM+ET +PL  +     +      + 
Sbjct: 81  AMNYLDRFLSLEPVKKSR---LQLLGATCMFVASKMKET-IPLTAEKLCIYTDNSIRPEE 136

Query: 185 IQRMELLVLSTLKWRMQAITPFSFLDYFTRKITDDDDDHH 224
           + +MELL+++ LKW + A+TP  F+++F  K+ + +++  
Sbjct: 137 LLQMELLLVNKLKWNLAAMTPHDFIEHFLSKMPEAEENKQ 176


>pdb|3G33|B Chain B, Crystal Structure Of Cdk4CYCLIN D3
 pdb|3G33|D Chain D, Crystal Structure Of Cdk4CYCLIN D3
          Length = 306

 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 16/205 (7%)

Query: 124 LTINYLDRFLSAYELPKGKVWMMQLLAVACLSLAAKMEETEVPLCLDLQVGQSKFLFEAK 183
           L +NYLDR+LS     K +   +QLL   C+ LA+K+ ET  PL ++     +      +
Sbjct: 94  LAMNYLDRYLSCVPTRKAQ---LQLLGAVCMLLASKLRET-TPLTIEKLCIYTDHAVSPR 149

Query: 184 TIQRMELLVLSTLKWRMQAITPFSFLDYFTRKITDDDDDHHQTPLRALFCRSIQIITS-S 242
            ++  E+LVL  LKW + A+    FL +   +++   D        AL  +  Q   +  
Sbjct: 150 QLRDWEVLVLGKLKWDLAAVIAHDFLAFILHRLSLPRDRQ------ALVKKHAQTFLALC 203

Query: 243 IKGIDFLEFKPSEIA-AAVAISVTGETKTVVDTEKAISLLTQHVKKERVLKCIKMMNDSL 301
                F  + PS IA  ++  +V G     +  ++   LL      E  + C++   + +
Sbjct: 204 ATDYTFAMYPPSMIATGSIGAAVQGLGACSMSGDELTELLAGITGTE--VDCLRACQEQI 261

Query: 302 ISGSVKSATSASLATS--FPQSPIG 324
            +   +S   A+  +S   P++P G
Sbjct: 262 EAALRESLREAAQTSSSPAPKAPRG 286


>pdb|1W98|B Chain B, The Structural Basis Of Cdk2 Activation By Cyclin E
          Length = 283

 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 99/203 (48%), Gaps = 20/203 (9%)

Query: 68  DECLALLLEKECHHLPHNDYLKRLRTGDLDLAARQEAVDWIAKVHSHFGFGPLCSYLTIN 127
           +E   ++L KE  +L    +L++     L    R   +DW+ +V   +       YL  +
Sbjct: 19  EEVWKIMLNKEKTYLRDQHFLEQ--HPLLQPKMRAILLDWLMEVCEVYKLHRETFYLAQD 76

Query: 128 YLDRFLSAYELPKGKVWMMQLLAVACLSLAAKMEETEVPLCLDLQVGQSKFLFEAK---- 183
           + DR+++  E       ++QL+ ++ L +AAK+EE   P     ++ Q  ++ +      
Sbjct: 77  FFDRYMATQENVVKT--LLQLIGISSLFIAAKLEEIYPP-----KLHQFAYVTDGACSGD 129

Query: 184 TIQRMELLVLSTLKWRMQAITPFSFLDYFTRKITDDDDDHH----QTPLRALFCRSIQII 239
            I  MEL+++  LKWR+  +T  S+L+ +  ++   +D H     Q P + +F +  +++
Sbjct: 130 EILTMELMIMKALKWRLSPLTIVSWLNVYM-QVAYLNDLHEVLLPQYP-QQIFIQIAELL 187

Query: 240 TSSIKGIDFLEFKPSEIAAAVAI 262
              +  +D LEF P  I AA A+
Sbjct: 188 DLCVLDVDCLEF-PYGILAASAL 209


>pdb|3IRS|A Chain A, Crystal Structure Of Uncharacterized Tim-Barrel Protein
           Bb4693 From Bordetella Bronchiseptica
 pdb|3IRS|B Chain B, Crystal Structure Of Uncharacterized Tim-Barrel Protein
           Bb4693 From Bordetella Bronchiseptica
 pdb|3IRS|C Chain C, Crystal Structure Of Uncharacterized Tim-Barrel Protein
           Bb4693 From Bordetella Bronchiseptica
 pdb|3K4W|A Chain A, Crystal Structure Of Uncharacterized Tim-Barrel Protein
           Bb4693 From Bordetella Bronchiseptica
 pdb|3K4W|B Chain B, Crystal Structure Of Uncharacterized Tim-Barrel Protein
           Bb4693 From Bordetella Bronchiseptica
 pdb|3K4W|C Chain C, Crystal Structure Of Uncharacterized Tim-Barrel Protein
           Bb4693 From Bordetella Bronchiseptica
 pdb|3K4W|D Chain D, Crystal Structure Of Uncharacterized Tim-Barrel Protein
           Bb4693 From Bordetella Bronchiseptica
 pdb|3K4W|E Chain E, Crystal Structure Of Uncharacterized Tim-Barrel Protein
           Bb4693 From Bordetella Bronchiseptica
 pdb|3K4W|F Chain F, Crystal Structure Of Uncharacterized Tim-Barrel Protein
           Bb4693 From Bordetella Bronchiseptica
 pdb|3K4W|G Chain G, Crystal Structure Of Uncharacterized Tim-Barrel Protein
           Bb4693 From Bordetella Bronchiseptica
 pdb|3K4W|H Chain H, Crystal Structure Of Uncharacterized Tim-Barrel Protein
           Bb4693 From Bordetella Bronchiseptica
 pdb|3K4W|I Chain I, Crystal Structure Of Uncharacterized Tim-Barrel Protein
           Bb4693 From Bordetella Bronchiseptica
 pdb|3K4W|J Chain J, Crystal Structure Of Uncharacterized Tim-Barrel Protein
           Bb4693 From Bordetella Bronchiseptica
 pdb|3K4W|K Chain K, Crystal Structure Of Uncharacterized Tim-Barrel Protein
           Bb4693 From Bordetella Bronchiseptica
 pdb|3K4W|L Chain L, Crystal Structure Of Uncharacterized Tim-Barrel Protein
           Bb4693 From Bordetella Bronchiseptica
          Length = 291

 Score = 29.6 bits (65), Expect = 2.5,   Method: Compositional matrix adjust.
 Identities = 15/57 (26%), Positives = 34/57 (59%), Gaps = 2/57 (3%)

Query: 275 EKAISLLTQHVKKERVLKCIKMMNDSLISGSVKSATSASLATSFPQS--PIGVLDAA 329
           EK++ L+ + +    + + + +  +S + GSV +A  A++A ++P    P+G ++AA
Sbjct: 46  EKSLELMFEEMAAAGIEQGVCVGRNSSVLGSVSNADVAAVAKAYPDKFHPVGSIEAA 102


>pdb|4EPA|A Chain A, The Crystal Structure Of The Ferric Yersiniabactin Uptake
           Receptor Fyua From Yersinia Pestis
          Length = 655

 Score = 27.7 bits (60), Expect = 8.5,   Method: Compositional matrix adjust.
 Identities = 12/21 (57%), Positives = 16/21 (76%), Gaps = 1/21 (4%)

Query: 24  DINGSVV-DEFENDATWHHGN 43
           DING+V+  EF ND+  +HGN
Sbjct: 526 DINGNVIRSEFTNDSELYHGN 546


  Database: pdbaa
    Posted date:  Mar 3, 2013 10:34 PM
  Number of letters in database: 14,973,337
  Number of sequences in database:  62,578
  
Lambda     K      H
   0.321    0.134    0.394 

Lambda     K      H
   0.267   0.0410    0.140 


Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 9,849,147
Number of Sequences: 62578
Number of extensions: 372717
Number of successful extensions: 1018
Number of sequences better than 100.0: 30
Number of HSP's better than 100.0 without gapping: 26
Number of HSP's successfully gapped in prelim test: 4
Number of HSP's that attempted gapping in prelim test: 964
Number of HSP's gapped (non-prelim): 30
length of query: 342
length of database: 14,973,337
effective HSP length: 100
effective length of query: 242
effective length of database: 8,715,537
effective search space: 2109159954
effective search space used: 2109159954
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 52 (24.6 bits)